학술논문
2312P SGLT2i dapagliflozin decreases NLRP3, IL-1 and PCSK9 expression in preclinical models of short-term doxorubicin cardiotoxicity
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1181-S1181
Subject
Language
ISSN
0923-7534